SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 31 filers reported holding SQZ BIOTECHNOLOGIES CO in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $254,093 | -51.8% | 941,086 | -0.1% | 0.00% | – |
Q1 2023 | $527,382 | -24.3% | 941,752 | 0.0% | 0.00% | – |
Q4 2022 | $696,896 | -67.5% | 941,752 | +0.0% | 0.00% | – |
Q3 2022 | $2,146,000 | -28.3% | 941,404 | 0.0% | 0.00% | – |
Q2 2022 | $2,994,000 | -39.0% | 941,404 | -7.8% | 0.00% | – |
Q1 2022 | $4,909,000 | -46.2% | 1,020,803 | -0.1% | 0.00% | – |
Q4 2021 | $9,129,000 | -37.7% | 1,022,245 | +0.7% | 0.00% | – |
Q3 2021 | $14,643,000 | +13.8% | 1,015,463 | +14.0% | 0.00% | – |
Q2 2021 | $12,868,000 | +154.5% | 890,577 | +141.0% | 0.00% | – |
Q1 2021 | $5,056,000 | -21.7% | 369,582 | +65.8% | 0.00% | – |
Q4 2020 | $6,460,000 | – | 222,903 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NanoDimension, Inc. | 1,445,221 | $12,906,000 | 11.57% |
683 Capital Management, LLC | 1,852,135 | $16,540,000 | 0.61% |
Sandy Cove Advisors, LLC | 51,707 | $462,000 | 0.39% |
Artal Group S.A. | 1,606,309 | $14,344,000 | 0.39% |
AMERICAN INTERNATIONAL GROUP, INC. | 2,529,272 | $22,586,000 | 0.11% |
MAVERICK CAPITAL LTD | 1,056,786 | $9,437,000 | 0.11% |
ACT CAPITAL MANAGEMENT, LLC | 16,000 | $143,000 | 0.10% |
Temasek Holdings (Private) Ltd | 2,758,169 | $24,630,000 | 0.09% |
BBR PARTNERS, LLC | 73,599 | $657,000 | 0.08% |
Redmond Asset Management, LLC | 17,206 | $154,000 | 0.04% |